Glenmark Pharmaceuticals Ltd - Stock Price

As on24 Sep 2021
  • NSE : GLENMARK
  • BSE : 532296
  • ISIN CODE : INE935A01035
  • Industry : Pharmaceuticals & Drugs
  • House : Glenmark
Glenmark Pharmaceuticals Ltd is not traded on BSE/NSE
508.10
-0.76 %-3.9
Previous Close 512.00
Day's Open 512.50
Bid Price (Qty) 0.00 (0)
Offer Price (Qty) 508.10 (2023)
Day’s High - Low 515.45 - 500.30
52 Week Range 442.05 - 690.95
Volume Traded (in 000's) 991.55
Value traded (in Cr.) 50.29
PE Ratio (x) 8.54
M Cap (in Cr.)14324.27

Glenmark Pharmaceuticals Ltd Stock Price

03/02/2017 | 15:19
  • Current Price8741.20
  • Open8735.15
  • High8748.25
  • Low8707.75
  • Prev. Close8734.25

Fundamentals

Parameter Values
Market Cap (Rs. in Cr.) 14324.27
Earning Per Share (EPS TTM) (Rs.) 59.41
Price To Earnings (P/E) Ratio 8.54
Book Value Per Share (Rs.) 497.03
Price/Book (MRQ) 1.02
Price/Earning (TTM) 7.83
ROCE (%) 12.54
PAT Margin 21.80
Dividend Yield 0.49
Face Value 1

Financial Summary

Parameter MAR 21 (`Mn.) MAR 20 (`Mn.) YoY %Change
Balance Sheet :
Share Capital282.17282.170.00
Total Non-Current Liabilities28036.1630330.06-7.56
Total Current Liabilities42010.2041259.831.82
Total Liabilities140689.09132291.026.35
Total Non-Current Assets67093.3064254.864.42
Currents Investments0.000.000.00
Cash and Bank11391.5711112.422.51
Total Current Assets73595.7968036.168.17
Total Assets140689.09132291.026.35
Profit & Loss :
Gross Sales109439.00106410.002.85
Net Sales109439.00106410.002.85
Total Expenditure88595.0089429.00-0.93
Operating Profit21346.0018577.0014.91
Profit After Tax9701.007760.0025.01
More from Financial Summary »

held by Mutual Fund Schemes

Scheme Holding(%)  
More from Held By MF Schemes »

News & Updates

  • There is no news in this stock

Share Holdings

Description Percent of Share (%)
Promoters46.63
Non-Institution16.82
Mutual Funds/Uti4.41
Fi/Banks/Insurance0.53
Government0
FII0
More from Share holdings »

Corporate Information

Management Info

  • Chairman: Glenn Saldanha
  • Managing Director: Glenn Saldanha
  • Secretary: Harish Kuber

Registered Office

Address : B/2 Mahalaxmi Chambers,22 Bhulabhai Desai Road, Mumbai,
Maharashtra-400026
Tel : Fax : Email : webmaster@glenmarkpharma.com Website : www.glenmarkpharma.com

Registars Details

K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

About Glenmark Pharmaceuticals Ltd.

Glenmark Pharmaceuticals Ltd. was incorporated in the year 1977. Its today's share price is 507.65. Its current market capitalisation stands at Rs 14324.27 Cr. In the latest quarter, company has reported Gross Sales of Rs. 75679.33 Cr and Total Income of Rs.79641.7 Cr. The company's management includes Harish Kuber, Dipankar Bhattacharjee, DR Mehta, Rajesh V Desai, Blanche Elizabeth Saldanha, Brian W Tempest, Saira Ramasastry, Sridhar Gorthi, Bernard Munos, Cherylann Pinto, VS Mani, Glenn Saldanha, Glenn Saldanha.

It is listed on the BSE with a BSE Code of 532296 , NSE with an NSE Symbol of GLENMARK and ISIN of INE935A01035. It's Registered office is at B/2 Mahalaxmi Chambers,22 Bhulabhai Desai Road, Mumbai-400026, Maharashtra. Their Registrars are ACC Ltd. It's auditors are Arthur Andersen & Associates, Price Waterhouse, Suresh Surana & Associates LLP, VK Bahri & Co, Walker Chandiok & Co LLP, Walker, Chandiok & Co, Walker, Chandiok & Co LLP

Latest News

close